Cargo Therapeutics
Cargo Therapeutics is a clinical-stage biopharmaceutical company focused on designing, engineering, and developing potentially curative next-generation cell therapies for cancer patients. The company's platform technologies and manufacturing strategy are designed to address limitations of approved cell therapies, including limited durability of effect, safety concerns, and availability.
Public Company
Cargo Therapeutics is publicly traded
IPO'd on Nov 10, 2023
This company is no longer available on our private secondary market. Shares can be traded publicly under CRGX.
Overview
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2019
Employees
76–167
Total Funding
$492M
3 rounds
Funding
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $492M across 3 rounds
Last updated 06-25-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Nov 10, 2023 | IPO | $281M | — | Public markets |
| Mar 1, 2023 | Series A Press release | $200M | — | Third Rock Ventures, RTW Investments, Perceptive Xontogeny Venture Fund |
| 2021 | Seed Press release | $11M | — | Samsara BioCapital |
Prominent Investors
Leadership
Crystal Mackall
Co-Founder
Nancy Goodman
Co-Founder
Robbie Majzner
Co-Founder, Chief Medical Officer
Louai Labanieh
Co-Founder
Gina Chapman
Chief Executive Officer (departed March 2025)
Anup Radhakrishnan
Interim Chief Executive Officer (appointed March 2025)
Halley Gilbert
Chief Legal Officer
Cargo Therapeutics Investment FAQ
Cargo Therapeutics FAQ
Yes, Cargo Therapeutics is publicly traded under the ticker symbol CRGX on the NASDAQ. The company went public in Nov 10, 2023.
Cargo Therapeutics trades under the ticker symbol CRGX on the NASDAQ. It began trading in Nov 10, 2023.
Cargo Therapeutics (CRGX on the NASDAQ) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker CRGX to place an order.
Cargo Therapeutics went public in Nov 10, 2023 via ipo. CARGO Therapeutics went public on NASDAQ (CRGX) on November 10, 2023, pricing 18.75M shares at $15/share, raising $281M. The company was subsequently acquired by Concentra Biosciences on July 8, 2025, for $4.379 per share in cash plus contingent value rights, following clinical setbacks with its lead CAR-T therapy candidate Firi-cel.
Cargo Therapeutics raised $492M across 3 disclosed funding rounds prior to its public listing.
Cargo Therapeutics was co-founded by Crystal Mackall, Nancy Goodman, Robbie Majzner, and 1 others in 2019.
Cargo Therapeutics is headquartered in San Carlos, CA, USA.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.